Location: Home
  • search
  • go
  • Relate News
  • 8/4/2015CDE Solicits Comments on Technical Guidelines for Clinical Trials of P...
  • 8/3/2015GSK Re-hires China Executive Linked to Whistleblowing Corruption Scand...
  • 8/3/2015Nestle Skin Health Launches SHIELD Center in Shanghai to Advance Healt...
  • 8/3/2015BeiGene Approved by CFDA to Initiate Phase I Study of Anticancer
  • 8/2/2015CFDA Seeks Public Comments on Certain Policy Measures for Resolving Dr...
  • 8/1/2015Chinese Animal Vaccine Industry Report 2015
  • 8/1/2015Tesaro and Jiangsu Hengrui Medicine Announce Rolapitant License Agreem...
  • 7/31/2015Upcoming Event: Finance for Non-Finance Professionals by Barry Johnson
  • 7/31/2015Upcoming Event: Training Evaluation and ROI Masterclass by Ron Drew St...
  • 7/31/2015Pharma Formulation Export Maintains Growth As Import Slows in H1
  • 7/31/2015CFDA Releases Its 2014 Annual Statistical Report
  • 7/31/2015GSK Announces Voluntary Price Reduction
  • 7/28/2015Why China's Public Healthcare Insurance Advancements Matter
  • 7/28/2015Alibaba Health, CPIC Test Water with Online Health Insurance
  • 7/28/2015NHFPC: Hepatitis B Incidence Drops in China
  • 7/28/2015CFDA Approves Clinical Study of New Chinese Indigenous Vaccine Against...
  • 7/28/2015Hengrui Medicine Enters Strategic Alliance with Shuwen Biotech for Cam...
  • 7/27/2015Rumors Emerge as BMI Uniform Payment Price Scheme Looms
  • 7/27/2015Latest Amendment of the PRC Drug Administration Law Reissued Officiall...
  • 7/27/2015China, Arab States Explore Healthcare Alliance
  • 7/27/2015KPMG: Indian Bulk Drug Industry Faces More Threat from Chinese API Imp...
  • 7/27/2015Yabao Pharma, Lawson Enter R&D Partnership for Sepsis Drug
  • 7/27/2015Eddingpharm to Initiate Phase I Trial of Cardiome's Cardiology Drug
  • 7/26/2015CFDA Seeks Comments on Draft "Testing Guidelines for Imported Dru...
  • 7/26/2015State Council Withdraws 62 Professional Qualifications Including Medic...
  • 7/24/2015China to Provide Universal Major Medical Insurance to Residents This Y...
  • 7/24/2015Bottlenecks for Development of China's Mobile Health Business
  • 7/24/2015Biosimilars Are Regulated Differently in China
  • 7/24/2015Shenzhen Hepalink Acquires A Sizable Stake in Resverlogix
  • 7/24/20153SBio Acquires Zhejiang Wansheng Pharmaceutical for $85M
  • Page:453/797 Total number of articles:23898: [First][<<] [451] [452] [453] [454] [455] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group